Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London

Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27, 2011 at 3:40 PM BST. During the presentation, a member of the company’s management team will provide a corporate overview, which may include a discussion of the company’s business activities and financial [...]

September 21, 2011  Tags: , , ,   Posted in: Chief executive officer, Emergent BioSolutions, Healthcare Conference, fuad el-hibri  No Comments

Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax

ROCKVILLE, Md., — Emergent BioSolutions Inc. (NYSE:EBS) announced on June 23rdthat the Singapore Health Sciences Authority (HSA) has approved Emergent’s product license application for the marketing and sale of BioThrax(R) (Anthrax Vaccine Adsorbed) in Singapore. BioThrax is the only vaccine licensed by the U.S. Food and Drug Administration (FDA) to protect against anthrax infection.
“Emergent is [...]

July 7, 2011  Tags: , , , , ,   Posted in: Biothrax, Chief executive officer, Emergent BioSolutions, Health Care, US Food and Drug Administration., fuad el-hibri  No Comments

Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors

ROCKVILLE, Md., Jun 13, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that its Chairman and Chief Executive Officer, Fuad El-Hibri, has been appointed to serve on the Board of Directors of the U.S. Chamber of Commerce. The U.S. Chamber of Commerce is the world’s largest business federation representing the interests of more [...]

June 20, 2011  Tags: , , , ,   Posted in: Chief executive officer, Emergent BioSolutions, entrepreneur, fuad el-hibri  No Comments

Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference

ROCKVILLE, Md., May 25, 2011 — Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in New York on Tuesday, June 7, 2011 at 1:15 PM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate [...]

June 1, 2011  Tags: , , , , ,   Posted in: Business, El-Hibri, Financial Performance, Healthcare Conference, Investors, fuad el-hibri  No Comments

Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference

Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the 10th Annual Needham & Company Healthcare Conference in New York on Tuesday, April 5, 2011 at 8:00 AM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of [...]

April 5, 2011  Tags: , , , ,   Posted in: Board of Directors, El-Hibri, Emergent BioSolutions, Healthcare Conference, fuad, fuad el-hibri  No Comments

Emergent BioSolutions to Release Fourth Quarter and Full Year 2010 Financial Results and Conduct a Conference Call on March 10, 2011

ROCKVILLE, Md., Feb 24, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today it will report financial results for the fourth quarter and full year 2010 on Thursday, March 10, 2011, after market close.
Company management will host a conference call at 5:00 pm Eastern on March 10, 2011 to discuss [...]

February 25, 2011  Tags: , , , , ,   Posted in: Biotechnology and Pharmaceuticals, CEO, Emergent BioSolutions, Research and development, fuad el-hibri  No Comments

CEO took roundabout path to Emergent

By Marjorie Censer
Monday, January 3, 2011
Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador.
But getting started in his current position as chief executive of Rockville-based pharmaceutical company Emergent BioSolutions took [...]

January 7, 2011  Tags: , , , , ,   Posted in: Biosolutions, Business, CEO, Department of Health and Human Services, El-Hibri, Emergent BioSolutions, Research and development, Trubion Pharmaceuticals, Yale University, fuad, fuad el-hibri  No Comments

Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals

ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion’s Seattle headquarters on October 28, 2010. The acquisition [...]

November 3, 2010  Tags: , , , ,   Posted in: Business, Emergent BioSolutions, Seattle, Trubion Pharmaceuticals, fuad el-hibri  No Comments

Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010

ROCKVILLE, Md., Oct 13, 2010 — Emergent BioSolutions Inc. (NYSE: EBS) announced today it will report financial results for third quarter 2010 on Thursday November 4, 2010, after market close.  Company management will host a conference call at 5:00 pm Eastern on November 4, 2010 to discuss the financial results for [...]

October 23, 2010  Tags: , , , , , , ,   Posted in: Anthrax vaccines, Biosolutions, Biothrax, Emergent BioSolutions, fuad el-hibri  No Comments

Fuad El-Hibri and The National Health Museum

The National Health Museum (NHM) is a science-based institution devoted to educating and inspiring Americans to live healthier lives. With an on site museum planned in Atlanta, and a web-based cyber museum, NHM is committed to bringing health science to life with exhibits, programs, and teaching strategies [...]

October 7, 2010  Tags: , , , , ,   Posted in: Atlanta, CEO, Emergent BioSolutions, National Health Museum, fuad el-hibri  No Comments